Putting Patients First Blog

JUNE 24, 2025

It will also negatively affect access to coverage and care for people that obtain their health coverage through the ACA Marketplace and Medicare. The proposed reconciliation bill heightens the risk that millions of Americans will lose access to care and coverage by shifting even more Medicaid costs to the states.

Insurance Coverage and Processing

Pharmacy Times

AUGUST 11, 2025

Most MTM platforms use health plan adjudication data, allowing pharmacists to see any medication billed through the patient’s insurance, even if it was not filled at their pharmacy. Accessed July 7, 2025. Accessed July 7, 2025. April 14, 2025. Accessed July 7, 2025. Accessed July 7, 2025. December 15, 2024.

Medication Therapy Management (MTM)

Pharmacy Times

JULY 22, 2025

These third-party administrators act as intermediaries between drug manufacturers, pharmacies, and insurance companies. PBMs negotiate prices, establish formularies, and process claims, while also creating preferred networks of pharmacies. March 17, 2025. Accessed June 4, 2025. J Am Pharm Assoc (2003). doi:10.1016/j.japh.2022.07.003

Pharmacy Technician

Pharmaceutical Technology

JULY 30, 2025

By incorporating a cell line from AvenCell into good manufacturing practice processes, ViroCell met the challenge of delivering a high-yield vector within the required timeframe. A first-in-human Phase I study involving patients with relapsed or refractory B-cell lymphoma is expected to commence using AVC-203 in the second half of 2025.

Insurance Coverage and Processing

Pharmacy Times

JULY 25, 2025

First-generation oral cephalosporins (ie, cephalexin and cefadroxil) have excellent coverage of methicillin-susceptible S aureus and Streptococcus spp, making them ideal agents for treatment. Typically, empiric coverage for UTIs includes Escherichia coli and Klebsiella pneumoniae.

HIV Treatment and Prevention Agents

Pharmaceutical Technology

JUNE 23, 2025

June 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook HBM7020 activates immune system T cells to target and destroy B cells and plasma cells involved in many autoimmune diseases. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Insurance Coverage and Processing

Pharmacy Times

JULY 1, 2025

SHOW MORE Pharmacists can help oversee the treatment process to ensure patients with transthyretin amyloid cardiomyopathy (ATTR-CM) are adhering to tafamidis. Because] insurance and cost barriers can be difficult for patients, pharmacists can help patients navigate copayment programs and the prior authorization process.”

HIV Treatment and Prevention Agents

Pharmacy Times

JULY 22, 2025

Personalized drug selection can lead to faster symptom control, fewer hospitalizations, and improved adherence—all of which contribute to better outcomes and a more streamlined care process. Real-World Evidence, Emerging Therapies, and Demonstrating Value Technological advances are accelerating this progress.

Pharmacy Technician

Pharmacy Times

JUNE 16, 2025

The first one was introduced on September 13, 2020, near the end of Trump’s first term, but was shut down by a federal judge due to the administration’s failure to comply with the proper implementation processes. Second, it does not address the core issues of higher prices, such as the use of rebates by insurers. May 12, 2025.

Pharmacy Technician

Pharmaceutical Technology

AUGUST 12, 2025

August 12, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The companies will work together using the NanoSpark tech to develop novel products to meet demands within the fast-growing cell and gene therapy markets. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Insurance Coverage and Processing

Pharmaceutical Commerce

JUNE 17, 2025

They also experience some of the same problems that manufacturers and distributors face, like spotty tracking information due to the manual processes associated with barcode scanning of drugs. Jeff Webber Key Takeaways Real-world data enhances medication safety and supply chain efficiency.

Health and Personal Care Stores

Pharmaceutical Technology

JUNE 27, 2025

June 27, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The alliance between the two entities will increase the production of new cancer therapies such as CAR T-cell treatment. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Insurance Coverage and Processing

Pharmaceutical Technology

JUNE 16, 2025

June 16, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Ethris’ platform technologies have shown favourable results in Phase I trials for ETH47. These platforms are designed for safe drug production while allowing scaleable manufacturing processes. Credit: Cryptographer/Shutterstock.

Insurance Coverage and Processing

Pharmacy Times

JULY 1, 2025

Rilonacept therapy management involves carefully evaluating patient disease stability, flare risks, and potential for discontinuation through a shared decision-making process. We on our own help to navigate patients through that process as well. That's an ongoing process, but that's one of the biggest questions.

Insurance Coverage and Processing

PharmaTech

AUGUST 1, 2025

This sweepstakes begins on August 4, 2025 at 12:01 a.m. ET and ends on August 14, 2025 at 11:59 p.m. ET on August 14, 2025. To be considered eligible, entries must be received no later than August 14, 2025 at 11:59 p.m. Void where prohibited by law. ET (“Promotion Period”). " by 5" white index card.

Dosage

Pharmaceutical Commerce

JULY 31, 2025

14 This is in the midst of various companies—such as Regeneron, Roche, Merck, and ThermoFisher—reshoring production to the United States in order to avoid paying these hefty tariffs—a process that can take years if the proper infrastructure is not already put in place. July 31, 2025. Accessed July 31, 2025. February 3, 2025.

Insurance Coverage and Processing

Pharmaceutical Commerce

JUNE 16, 2025

24 Hours in the Hub Still Matters More June 16, 2025 By Chris Dowd, ConnectiveRx Commentary Article Pharmaceutical Commerce Pharmaceutical Commerce - June 2025 Volume 20 Issue 3 Doubling down on patient access and support fundamentals will win out over Washington’s next move. Chris Dowd Key Takeaways Speed is Critical.

Insurance Coverage and Processing

Pharmaceutical Commerce

JULY 29, 2025

July 28, 2025. Accessed July 29, 2025. July 23, 2025. Accessed July 29, 2025. July 28, 2025. Accessed July 29, 2025. July 25, 2025. Accessed July 29, 2025. July 25, 2025. Accessed July 29, 2025. Saraceno N. EU Threatens 30% Tariffs on $117 Billion of US Goods Amid Trade Standoff.

Insurance Coverage and Processing

Beckers Hospital Review

AUGUST 1, 2025

Amick was appointed CEO of Visante in July 2025, bringing over 30 years of leadership experience in healthcare technology and services to the organization. Mr. Angelone, co-founder and chief commercial officer of MacroHealth, has over 25 years of experience in the health insurance and technology industries. CEO of Visante (St.

Insurance Coverage and Processing

Pharmaceutical Commerce

JULY 16, 2025

I'll explain why this "gold rush" is fraught with peril, from a risk management and insurance perspective. The elephant in the room: The critical absence of FDA approval The fundamental issue with compounded GLP-1s lies in their sidestepping of the rigorous FDA approval process.

Compounding

Pharmaceutical Commerce

AUGUST 12, 2025

2 The following cases underscore the importance of diligence and vigilance in our procurement processes. 3 Thus far in 2025, the case making news has involved counterfeit Ozempic, which has become a target of illicit traders since its market launch. April 14, 2025. Nicholas Saraceno, Editor August 12th 2025 Serialization 2.0:

Packaging

Pharmaceutical Technology

JULY 7, 2025

July 7, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The collaboration will advance paediatric healthcare by focusing on cell and gene therapies. This alliance seeks to bolster clinical trial capabilities through improved regulatory processes and data governance. Credit: Department of Health Abu Dhabi.

Hospitals

Pharmacy Times

JULY 24, 2025

Someone ended up donating a car, and they used the money to buy tires and insurance. It seems to streamline the process,” Loy-Helm said. Because the pharmacy is in a rural area, Loy-Helm explained, patients have her phone number. One service at Russell Springs Pharmacy is pill packing. People love it.

Independent Pharmacies

Pharmaceutical Technology

JUNE 6, 2025

Robert Barrie June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook US health secretary Robert F Kennedy Jr. The approval process for cell and gene therapy candidates is tricky, however, given their high-cost and oft-debated benefit-risk ratio. Topic sponsors are not involved in the creation of editorial content.

Insurance Coverage and Processing

Pharmaceutical Commerce

AUGUST 11, 2025

For the second year in a row, patients with chronic conditions rated health plan access a “D,” with nearly half facing insurance-related barriers like high cost-sharing, formulary restrictions, and prior authorization. Barriers are worsening in 2025.

Insurance Coverage and Processing

Pharmaceutical Commerce

JULY 23, 2025

Many companies have already been in the process of reshoring manufacturing to the United States to avoid the impending tariffs, including AstraZeneca, who plans to invest $50 billion by 2030 in US-based drug manufacturing and R&D, marking its largest single manufacturing investment globally. July 23, 2025. Accessed July 23, 2025.

Insurance Coverage and Processing

Pharmaceutical Technology

JUNE 30, 2025

Robert Barrie June 30, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook CAR-Ts, the first of which were initially approved in June 2025, have demonstrated a wealth of efficacy in haematological oncology indications. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Insurance Coverage and Processing

Pharmaceutical Technology

JUNE 20, 2025

June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The treatments can be accessed through facilities such as Royal Prince Alfred Hospital, Westmead Hospital and the Sydney Children’s Hospitals Network. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 1, 2025

Robert Barrie July 1, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Shares in NYSE-listed AbbVie closed 1.7% Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. higher following the deal. Valeriya Zankovych via Shutterstock.

Insurance Coverage and Processing

Pharmacy Times

JULY 25, 2025

Insurance coverage for GLP-1 medications can be a barrier, as they are often not covered for non-diabetic uses, necessitating pharmacist guidance. 1 It is important to remember that insurance coverage for GLP-1 medications can be a barrier for patients, particularly amid shortages and changes in medications that are being covered.

Insurance Coverage and Processing

Pharmaceutical Commerce

JUNE 18, 2025

Click here to view our interactive June 2025 issue! June 18th 2025 Article The June issue of Pharmaceutical Commerce highlights the importance of embracing agility—and adaptable strategies—to better navigate industry challenges.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 9, 2025

July 9, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The JUST-AAV platform features a range of vector types optimised for several target tissues, enhancing the potential of AAV-based gene therapy. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 14, 2025

Robert Barrie July 14, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Broader label coverages for Pfizer and Moderna’s vaccines mean they have made in-roads into GSK’s RSV dominant market share. MAXSHOT.PL via Shutterstock. Give your business an edge with our leading industry insights.

Labelling

Pharmaceutical Technology

JULY 22, 2025

Abigail Beaney July 22, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Sarepta will pause shipments of the therapy to the US while it discusses the therapy with the FDA. Sarepta confirmed it will work with the FDA to respond to requests for information while advancing the Elevidys safety labelling supplement process.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 29, 2025

Robert Barrie and Abigail Beaney July 29, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The FDA determined the third patient death after treatment with Elevidys was not linked to the gene therapy. GlobalData forecasts full-year 2025 revenue for Elevidys of $1.41bn. Image credit: T.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 14, 2025

July 14, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The rare and fatal lysosomal storage disorder primarily impacts the brain. The company is confident that these concerns, which pertain to facilities and processes rather than product quality, can be promptly addressed. Credit: Kateryna Kon/Shutterstock.

Insurance Coverage and Processing

Pharmaceutical Commerce

JULY 1, 2025

1 There are specific diseases—including hemophilia and sickle cell disease (SCD)—that are more widespread in groups enrolled in Medicaid than commercially insured individuals, due to the program’s concentration on children, disabled adults, and those families financially impacted by treatment costs. of average manufacturer price.

Insurance Coverage and Processing